Results 161 to 170 of about 136,885 (261)

Oligoclonal B cell expansion and passenger fusion genes predict response to Nivolumab in recurrent ovarian cancer: phase II Kyoto trial. [PDF]

open access: yesCancer Immunol Immunother
Murakami R   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy